Darzalex

Daratumumab · Injection, Solution, Concentrate · Intravenous

Prescription (Rx) CD38-directed Cytolytic Antibody

No FDA structured label text is available for Darzalex. The NDC listings below come from the FDA National Drug Code directory.

Active ingredients

Darzalex NDC products (1)

NDCStrength & formLabelerType
57894-502Daratumumab 100 mg/5mL
Injection, Solution, Concentrate
Janssen Biotech, Inc.BLA

Frequently asked questions

Who makes Darzalex?

Darzalex is listed by 1 labeler in the FDA NDC directory, including Janssen Biotech, Inc..